Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

TELIX-IlluccixApprove

More Like This

PR Newswire associated0

Illuccix® Approved in the United Kingdom

PR Newswire associated0

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

PR Newswire associated0

Illuccix® Receives European Approval

PR Newswire associated0

Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region

PR Newswire associated0

Telix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM)

PR Newswire associated0

Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®

PR Newswire associated0

Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer

PR Newswire associated0

Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent